Join the leading pharma, biotechs, academic researchers, and their partners to discuss how to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.
Companies already confirmed include:
- Janssen
- The Microbiome Center University of Chicago
- GlaxoSmithKline
- M.D. Anderson Cancer
- University of California San Diego
- Harvard Medical School
- Seres Therapeutics
- Joslin Diabetes Center
- Cedars Sinai Medical Center
- NIH
- Openbiome
- F.D.A
- Siolta Therapeutics
- Pfizer
- University of Maryland School of Medicin
- Assembly Biosciences, Inc.
- Vedanta Biosciences Inc
